SCOR participated in a trial organized by the Chief Risk Officer Forum to design a common taxonomy that could be used to capture digital events.
- FR
- EN
SCOR participated in a trial organized by the Chief Risk Officer Forum to design a common taxonomy that could be used to capture digital events.
Foot and Mouth Disease (FMD): Under certain circumstances, diseases like FMD are (re)insurable
SCOR’s 2017 Registration Document (“Document de Référence”) was filed with the French financial market authority, the Autorité des marchés financiers (AMF), on February 23, 2018
Registration Document 2017
SCOR’s 2017 Registration Document (“Document de Référence”) was filed with the French financial market authority, the Autorité des marchés financiers (AMF), on February 23, 2018.
Presentation of 2017 Annual Results
2017 Annual Results
On February 12, the 5th SCOR Young European Researcher Prize for Research into Alzheimer’s disease was presented to Erik Portelius of Sweden’s Gothenburg University, for his findings on a new biomarker that enables ea
SCOR Investment Partners, the SCOR group’s portfolio management company, announces the launch of its eighth leveraged loans fund - SCOR MID MARKET LOANS - in partnership with LBO France, one of the pioneers of private
SCOR Investment Partners, the SCOR group’s portfolio management company, announces the launch of its eighth leveraged loans fund - SCOR MID MARKET LOANS - in partnership with LBO France, one of the pioneers of private
This Technical Newsletter looks at a disease that infects several types of farm animals and causes significant losses, both within and beyond the agricultural sector: foot and mouth disease (FMD) and how, under certai
Pagination